Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
Therapeutic Advances in Medical Oncology|June 12, 2025
Impact of low hormone receptor expression on neoadjuvant chemotherapy response and patterns of care in non-metastatic HER2-negative breast cancer: a US National Cancer Database analysisDionisia Quiroga, Charles Pei, Julie A Stephens, et al.Journal of the National Cancer Institute|September 22, 2018
Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast CancerJinani Jayasekera, Clyde B Schechter, Joseph A Sparano, et al.NPJ Breast Cancer|September 27, 2017
Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study designJennifer A Ligibel, William T Barry, Catherine Alfano, et al.JAMA Oncology|April 22, 2021
Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 TrialSteve Chmura, Kathryn A Winter, Clifford Robinson, et al.International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast RecurrenceDouglas W Arthur, Kathryn A Winter, Henry M Kuerer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observationBeryl McCormick, Kathryn Winter, Clifford Hudis, et al.NPJ Breast Cancer|October 12, 2019
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancerDavid B Page, Harry Bear, Sangeetha Prabhakaran, et al.Journal of the National Cancer Institute|May 3, 2018
Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast CancerJinani Jayasekera, Yisheng Li, Clyde B Schechter, et al.JAMA Oncology|April 12, 2019
Current Landscape of Immunotherapy in Breast Cancer: A ReviewSylvia Adams, Margaret E Gatti-Mays, Kevin Kalinsky, et al.Obesity (Silver Spring, Md.)|December 21, 2021
The Breast Cancer Weight Loss trial (Alliance A011401): A description and evidence for the lifestyle interventionLinda M Delahanty, Thomas A Wadden, Pamela J Goodwin, et al.Pageof 8